Synthesis of 7-Epi (+)-FR900482

B. M. Trost; B. M. O’Boyle

doi:10.1055/s-2008-1078286

RSS-Feed abonnieren

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000131.xml

Teilen / Bookmarken

Facebook X Linkedin Weibo

PDF herunterladen

Synfacts 2008(10): 1017-1017
DOI: 10.1055/s-2008-1078286

Synthesis of Natural Products and Potential Drugs

Synthesis of 7-Epi (+)-FR900482

Contributor(s): Philip Kocienski, Indu Dager
B. M. Trost*, B. M. O’Boyle
Stanford University, USA

Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. September 2008 (online)

Lizenzen und Reprints

Significance

Due to its superior activity against several cancer cell lines and decreased toxicity compared to mitomycin C, FR900482 has been investigated as a replacement candidate for mitomycin C. The synthesis of key intermediate E features a highly stereoselective Pd-catalyzed DYKAT (dynamic catalytic asymmetric transformation) reaction.